VCBeat Health
Contact Us
Home
China Healthcare Select
Insights
MNC China Lens
Vertical Industries
Services
Partnership Development
Market Entry Advisory
Ecosystem Engagement Advisory
About VCBeat
Why VCBeat
Log In
Home
iCell Therapeutics: Dual Milestone — iNK-1001 IND Accepted, PB-ZRAK Clinical Trial Approved
iCell Therapeutics: Dual Milestone — iNK-1001 IND Accepted, PB-ZRAK Clinical Trial Approved
Jun 01, 2026 15:20 CST Updated 15:59
Share:
